NCT01840332View on ClinicalTrials.gov

Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Thyroid Cancer
Interventions
DRUG

L-thyroxin

Low dose of L-thyroxin (50 microg/day) will be used during 4 weeks. If TSH is \< 30 after 4 weeks the study continues up to 6 weeks.

Trial Locations (2)

10138

East Tallinn Central Hospital, Tallinn

50406

Tartu University Hospital, Tartu

All Listed Sponsors
lead

University of Tartu

OTHER

NCT01840332 - Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer | Biotech Hunter | Biotech Hunter